KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Payables (2017 - 2025)

Historic Payables for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $352.0 million.

  • Elanco Animal Health's Payables rose 3590.73% to $352.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $352.0 million, marking a year-over-year increase of 3590.73%. This contributed to the annual value of $296.0 million for FY2024, which is 962.96% up from last year.
  • Elanco Animal Health's Payables amounted to $352.0 million in Q3 2025, which was up 3590.73% from $368.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Payables high stood at $506.0 million for Q2 2021, and its period low was $259.0 million during Q3 2024.
  • Moreover, its 5-year median value for Payables was $354.0 million (2023), whereas its average is $357.7 million.
  • In the last 5 years, Elanco Animal Health's Payables surged by 10865.98% in 2021 and then crashed by 3076.92% in 2023.
  • Elanco Animal Health's Payables (Quarter) stood at $416.0 million in 2021, then decreased by 6.25% to $390.0 million in 2022, then plummeted by 30.77% to $270.0 million in 2023, then increased by 9.63% to $296.0 million in 2024, then increased by 18.92% to $352.0 million in 2025.
  • Its last three reported values are $352.0 million in Q3 2025, $368.0 million for Q2 2025, and $330.0 million during Q1 2025.